Allelica Licenses University of Cambridge BOADICEA Model to Deliver Comprehensive Breast Cancer Risk Assessment
PR Newswire —
SAN FRANCISCO, Jan. 22, 2026 /PRNewswire/ -- Allelica, a precision medicine company focused on genomic risk assessment for common diseases, today announced that it has entered into a commercial license agreement with Cambridge Enterprise, the innovation office of the University of...